|
ZC3H15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84199999997414E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.00169999972933E-07 |
| Normal-vs-Stage2 |
3.017900E-02 |
| Normal-vs-Stage3 |
3.487800E-01 |
| Normal-vs-Stage4 |
6.914600E-01 |
| Stage1-vs-Stage2 |
4.168400E-01 |
| Stage1-vs-Stage3 |
4.285900E-02 |
| Stage1-vs-Stage4 |
1.650420E-02 |
| Stage2-vs-Stage3 |
4.065400E-01 |
| Stage2-vs-Stage4 |
8.466200E-02 |
| Stage3-vs-Stage4 |
3.819000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.2739999999688E-06 |
| Normal-vs-AfricanAmerican |
3.848800E-04 |
| Normal-vs-Asian |
9.122600E-01 |
| Caucasian-vs-AfricanAmerican |
8.613000E-01 |
| Caucasian-vs-Asian |
1.447840E-01 |
| AfricanAmerican-vs-Asian |
1.424220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.42250000457045E-09 |
| Normal-vs-Female |
6.377400E-01 |
| Male-vs-Female |
3.79900000000433E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.624700E-03 |
| Normal-vs-Extreme_Weight |
1.98969996034748E-09 |
| Normal-vs-Obese |
5.479700E-03 |
| Normal-vs-Extreme_Obese |
9.089600E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.344790E-01 |
| Normal_Weight-vs-Obese |
6.410000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.998000E-01 |
| Extreme_Weight-vs-Obese |
2.493800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.114600E-01 |
| Obese-vs-Extreme_Obese |
7.830200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.587000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.377560E-04 |
| Normal-vs-Age(61-80Yrs) |
5.68080000040716E-07 |
| Normal-vs-Age(81-100Yrs) |
2.435900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.865800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.619400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.271810E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.366400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.342990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.140600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.50739995433236E-09 |
| Normal-VS-Type2 PRCC |
5.354200E-02 |
| Normal-VS-KIRP CIMP |
3.831600E-02 |
| Normal-VS-Unclassified PRCC |
1.504440E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.665610E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.38860000165053E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
2.196000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.775500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.086600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.33709999999787E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.86920000000423E-06 |
| Normal-vs-N1 |
1.412960E-01 |
| Normal-vs-N2 |
8.243600E-01 |
| N0-vs-N1 |
2.807400E-04 |
| N0-vs-N2 |
1.739760E-01 |
| N1-vs-N2 |
4.311000E-01 |
|
|
